Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Article History

Received : 05-08-2024

Accepted : 16-10-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 123

PDF Downloaded: 29


Challenges and complications of using EZ™ bronchial blocker in minimally invasive coronary artery bypass grafting surgery: A case series


Full Text PDF


Case Series

Author Details : Arupratan Maiti*, Sreya Moitra, Amrita Guha

Volume : 11, Issue : 4, Year : 2024

Article Page : 588-592

https://doi.org/10.18231/j.ijca.2024.104



Suggest article by email

Get Permission

Abstract

We present a case series of challenges and complications of using Rusch EZ blocker™ (Teleflex Life Sciences Ltd., Athlone, Ireland), a specially designed semi rigid Y shaped bronchial blocker containing two inflatable cuffs. We describe fifteen different patients (out of eighty four attempted EZ blockers) undergoing MICS CABG, in whom we faced different technical difficulties and adverse effects while using EZ blocker. We report failed EZ blocker insertion due to anatomical reasons, misplaced blocker following insertion and also few manufacturer defects. We have also encountered hemodynamic instability and bronchial injury in small percentage of cases. The EZ blocker is an easy, safe and reliable device for lung isolation but clinicians must know, prevent and solve the unexpected associated troubles which can happen acutely during insertion or insidiously post endobronchial placement.
 

Keywords: EZ bronchial blocker, Malposition, Fibreoptic bronchoscope, Lung isolation.



How to cite : Maiti A, Moitra S, Guha A, Challenges and complications of using EZ™ bronchial blocker in minimally invasive coronary artery bypass grafting surgery: A case series. Indian J Clin Anaesth 2024;11(4):588-592


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.